Overview
Roy Drissen practices practicing medicine in Oxford, United Kingdom.
His clinical expertise encompasses Acute Erythroid Leukemia (AEL) and Acute Myeloid Leukemia (AML).
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Roy Drissen
Is Roy Drissen a top-rated expert for Acute Erythroid Leukemia (AEL)?
MediFind is an objective health platform that identifies experts based on real-world data. Roy Drissen is classified as an Experienced expert for Acute Erythroid Leukemia (AEL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Roy Drissen participate in research or clinical trials?
Yes. Roy Drissen has published 11 articles and abstracts on conditions like Acute Erythroid Leukemia (AEL). You can view a list of Roy Drissen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Erythroid Leukemia (AEL)Mr. Drissen isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Myeloid Leukemia (AML)Mr. Drissen isExperienced. Learn about Acute Myeloid Leukemia (AML).